Harmony Biosciences: Q3 WAKIX net revenue of $269 million and full-year guidance reiterated
FROM THE WIRE · GLOBENEWSWIRE.COM
WAKIX ® Net Revenue in Q3 of $269 Million; Driven by Strong Demand with 400 Net Patient Adds in the Quarter; Reiterates Full Year Guidance of $1.0B to $1.04B
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishStrong quarterly revenue and reiterated guidance matter for the stock, though the update is largely in line with stated expectations.AI-generated summary
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets